Mark Patrick Guerin - 10 Jun 2022 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ONTX	Stock Option (right to purchase)	Award	$0	+50,250		$0.000000	50,250	10 Jun 2022	Common stock	50,250	$1.33	Direct	F1
transaction	ONTX	Restricted Stock Units	Award	$0	+16,500		$0.000000	16,500	10 Jun 2022	Common stock	16,500		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
F2	These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.
F3	Each restricted stock unit is convertible into one share of common stock.